Breast Cancer Screening Ai Platform

A primary diagnostic solution for breast cancer diagnosis that is powered by AI and has been accredited with CE marking.+10.0The solution is utilized in the clinical routine of laboratories and clinics.+14.0

Pathologists participated in the clinical study.plus twenty-five

It was constructed through the collaboration of physicians.input:
output:I am interested in

Cleo Breast?

Enhance your workflow with an AI solution that you can rely on.



An all-in-one primary diagnostic solution powered by AI, Cleo Breast has been accredited with CE marking. For clinical applications, we collaborated with European reference laboratories to automate the detection and quantification of tumor biomarkers in breast tissue.input:
output:Cleo Breast is intended to identify the presence or absence of specific biomarkers in breast tissue lesions through numerized image analysis of histological Whole Slide Images (WSI or digitized slides of histological tissue samples).input:
output:Cleo breast offers pathologists and laboratory experts an automatic and efficient reading of breast cancer diagnosis that is fully integrated into the laboratory workflow and can be fully integrated with the laboratory machines.input:
output:Accredited physicians are required to evaluate the results of Cleo Breast, which is designed to serve as a diagnostic aid.input:
output:Characteristics

Detection of biomarkersinput:
output:Invasive and in situ carcinoma

Detects the Invasive Carcinoma and In Situ Carcinoma regions with high precision and presents the results in a heatmap.input:
output:MitosisIdentifies all mitosis objects and mitosis hotspots in the carcinoma regions. Additionally, the algorithm executes an automated mitosis count.input:
output:CalculationsIdentifies each potential calcification object. In order to facilitate the pathologist's analysis, certain calcification tiles are displayed.